[Results of the treatment in patients with pulmonary tuberculosis excreting bacilli in primary resistance to antitubercular drugs]. 1965

S Hornung, and M Polończyk

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

S Hornung, and M Polończyk
November 1964, Gruzlica (Warsaw, Poland : 1926),
S Hornung, and M Polończyk
February 1974, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
S Hornung, and M Polończyk
February 1998, Schweizerische medizinische Wochenschrift,
S Hornung, and M Polończyk
May 1965, Polski tygodnik lekarski (Warsaw, Poland : 1960),
S Hornung, and M Polończyk
January 1968, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
S Hornung, and M Polończyk
July 1971, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
S Hornung, and M Polończyk
February 1971, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
S Hornung, and M Polończyk
April 1962, Gruzlica (Warsaw, Poland : 1926),
S Hornung, and M Polończyk
July 1971, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
Copied contents to your clipboard!